Search results for: 'partnering deaf alliance with big biotech'
- Did you mean
- partnering deal alliances with big biotech
- Related search terms
- Partnering Terms and Agreements in Diagnostics
- Bigpharma Partnering Yearbook 2014
- Bigpharma Deals and Alliances of 2013
- Bigpharma Partnering Yearbook
- partnering agreements with optimer pharmaceutical 221b 221b
-
Diagnostic Imaging Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Diagnostic Imaging Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Oncology Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
Cancer Diagnostic Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Cancer Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Stem Cell Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Stem Cell Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Genitourinary Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Genitourinary Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Antibody Collaboration and Licensing Deals 2019-2024May 2024$3,995.00Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Bioinformatics Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Bioinformatics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology DealsSeptember 2024$3,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2024 | Over a decade of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Licensing Deals in Pharmaceuticals 2019-2024September 2024$3,995.00Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More
